Young convalescent COVID‐19 pneumonia with extensive pneumomediastinum emphysema: Case report
Open Access
- 27 March 2022
- journal article
- research article
- Published by Wiley in Clinical Case Reports
- Vol. 10 (3) , e05543
Abstract
The development of the SARS‐CoV‐2 pandemic caused a common appearance of severe pulmonary complications, rarely seen as a result of the other infections. These are pneumothorax, pneumomediastinum, emphysematous bullae, cavitary lung lesions, or subcutaneous emphysema. Their formation is influenced by both—the natural course of the disease and the treatment strategy adopted.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcomeThrombosis Research, 2021
- Interstitial lung disease-related pneumomediastinum in COVID-19 patientsERJ Open Research, 2021
- Spontaneous subcutaneous emphysema and pneumomediastinum in non-intubated patients with COVID-19Clinical Imaging, 2020
- Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?ERJ Open Research, 2020
- Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer LevelsRadiology, 2020
- Pulmonary embolism in COVID-19 patients: a French multicentre cohort studyEuropean Heart Journal, 2020
- Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 PatientsAmerican Journal of Roentgenology, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, ChinaInternational Journal of Infectious Diseases, 2020
- Pneumomediastinum and subcutaneous emphysema after noninvasive ventilation in a COVID-19 patientAdvances in Respiratory Medicine, 2020